Summer Street's chief scientific officer holds analyst/industry conference call. Chief Scientific Officer Classen discusses whether the upcoming January 14th meeting of the FDA's Cardiovascular and Renal Drugs Advisory Committee will approve Chelsea Therapeutics' Northera on an Analyst/Industry conference call to be held on January 10 at 12:30 pm.
These thoughts are just mine, not right, not wrong, just thoughts. Invest in what you believe in, not what I believe in. Do your research, and invest in the facts.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.